TTOO (T2 Biosystems) Total Stockholders Equity: $-11.71 Mil (As of Sep. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TTOO T2 Biosystems Inc TTOO
12 GF Score
Price $0.00
View Full Analysis

What is T2 Biosystems Total Stockholders Equity?

T2 Biosystems TTOO +150.00% 12 Total Stockholders Equity is $-11.71 Mil as of Sep. 2024. GuruFocus rates TTOO with a GF Score™ of 12/100.

T2 Biosystems's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $-11.71 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. T2 Biosystems's Book Value per Share for the quarter that ended in Sep. 2024 was $-0.62. The ratio of a company's debt over equity can be used to measure how leveraged this company is. T2 Biosystems's Debt-to-Equity for the quarter that ended in Sep. 2024 was -1.62.


T2 Biosystems  (OTCPK:TTOO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

T2 Biosystems's Book Value per Share for the quarter that ended in Sep. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

T2 Biosystems's Debt-to-Equity for the quarter that ended in Sep. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


T2 Biosystems Total Stockholders Equity Related Terms


T2 Biosystems Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for T2 Biosystems's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T2 Biosystems Total Stockholders Equity Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.01 8.73 -12.90 -39.66 -28.04

T2 Biosystems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.24 -28.04 -37.77 -5.90 -11.71
TTOO
12GF Score
T2 Biosystems Inc TTOO
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $-11.71 Mil mean?
T2 Biosystems (TTOO) has a Total Stockholders Equity of $-11.71 Mil as of Sep. 2024. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for T2 Biosystems and its competitors.
Is T2 Biosystems' Total Stockholders Equity too high?
T2 Biosystems' current Total Stockholders Equity is $-11.71 Mil. Overall, T2 Biosystems has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does T2 Biosystems' Total Stockholders Equity compare to IDTA and NSTM?
T2 Biosystems' Total Stockholders Equity of $-11.71 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Diagnostics & Research company?
A good Total Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for T2 Biosystems and its competitors. T2 Biosystems's current Total Stockholders Equity is $-11.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T2 Biosystems stock overvalued right now?
T2 Biosystems (TTOO) has a current Total Stockholders Equity of $-11.71 Mil. The current Total Stockholders Equity is $-11.71 Mil. T2 Biosystems' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For T2 Biosystems (TTOO), the current Total Stockholders Equity is $-11.71 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T2 Biosystems Business Description

Address 101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
12GF Score

Get the complete analysis for TTOO

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price